Alirocumab and cardiovascular outcomes after acute coronary syndrome

ODYSSEY OUTCOMES Committees and Investigators, G. G. Schwartz, P. G. Steg, M. Szarek, D. L. Bhatt, V. A. Bittner, R. Diaz, J. M. Edelberg, S. G. Goodman, C. Hanotin, R. A. Harrington, J. W. Jukema, G. Lecorps, K. W. Mahaffey, A. Moryusef, R. Pordy, K. Quintero, Matthew T. Roe, W. J. Sasiela, J. F. TambyP. Tricoci, Harvey D. White, A. M. Zeiher, Philip E. Aylward, Sam J. Lehman

Research output: Contribution to journal › Article › peer-review

2439 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alirocumab and cardiovascular outcomes after acute coronary syndrome'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science